Episodios

  • MDMA Therapy vs. PTSD: Which is Safer? Featuring Dr. John Miller MD

    MDMA Therapy vs. PTSD: Which is Safer? Featuring Dr. John Miller MD
    Aug 9 2024
    In this episode, Dr. Dave Rabin is joined by Dr. John J. Miller, a renowned clinical psychopharmacologist, to discuss the significance of the upcoming FDA decision on MDMA therapy for PTSD.

    John J. Miller, M.D. is Medical Director at Brain Health in Exeter, New Hampshire and has served as the Editor-in-Chief for Psychiatric Times since February 2019. He has worked for 38 years as a clinical psychopharmacologist, most recently 17 years as a Staff Psychiatrist at Seacoast Mental Health Center in Exeter, NH. Dr. Miller completed his B.S. in Biochemistry at the University of MA/Amherst. And medical school and residency in Adult Psychiatry at the University of MA Medical School/Worcester. He is a Diplomate of the American Board of Psychiatry and Neurology. Since 1998 he has presented more than 3,000 lectures throughout the US on a wide range of psychiatric topics including PTSD. You can find Dr. Miller in his monthly editorials for Psychiatric Times that he has been authoring since March 2019.

    Discover the history of PTSD treatment, the current limitations of existing medications, and the promising results of MDMA-assisted therapy trials. Learn about the bipartisan support from lawmakers and the urgent need for FDA approval to provide relief to millions suffering from PTSD.

    Don't miss this insightful conversation on the potential paradigm shift in mental health treatment. Stay informed and advocate for change by tuning in to The Psychedelic Report.

    Brain Health in Exeter, New Hampshire (http://www.brain-health.co)
    Psychiatric Times (http://www.psychiatrictimes.com)
    https://x.com/PsychTimes?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor

    https://www.linkedin.com/in/jjmillermd/

    https://www.linkedin.com/company/psychiatric-times/

    www.apolloneuro.com

    FDA petition for MDMA-assisted therapy
    https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/
    Más Menos
    34 m
  • Dispelling the False Claims about MAPS and MDMA-Assisted Therapy

    Dispelling the False Claims about MAPS and MDMA-Assisted Therapy
    Aug 5 2024
    In this episode, Dr. Dave Rabin MD, PhD is joined by Dr. Geoff Bathje PhD who authored an article published on July 19, 2024 in Chacruna entitled: “The Unbelievable Claims of Psymposia about MAPS and MDMA-Assisted Therapy.”Dr. Bathje and Dr. Rabin discuss the recent FDA Advisory Committee vote on MDMA-assisted therapy for PTSD, which surprisingly and wrongfully concluded that the benefits do not outweigh the risks. This conversation deep dives into Dr. Bathje’s report on how Psymposia, what appears to be a group of fringe radicals, negatively biased the FDA committee's vote on June 4 by writing letters with false and misleading claims in an attempt to prevent the clearance of MDMA for PTSD. Why would anyone not only want to prevent clearance of MDMA therapy for Veterans, but see themselves as heroes for doing so? Find out all that and more in this weeks episode of The Psychedelic Report.


    The Unbelievable Claims of Psymposia about MAPS and MDMA-Assisted Therapy by Dr. Geoff Bathje: https://chacruna.net/unbelievable-claims-of-psymposia-about-maps-and-mdma-assisted-therapy/
    • Web: https://psychedelic.support/
    • Twitter: https://twitter.com/DrDavidRabin
    • Instagram: https://www.instagram.com/drdavidrabin
    • Web: https://www.drdave.io/

    FDA petition for MDMA-assisted therapy https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/
    Food and Drug Administration5630 Fishers LaneRm. 1061Rockville, MD 20852Docket No. FDA-2024-N-193
    Más Menos
    45 m
  • MDMA Therapy and the FDA Advisory Committee’s Bias with Jesse Gould

    MDMA Therapy and the FDA Advisory Committee’s Bias with Jesse Gould
    Jul 25 2024
    In this episode of The Psychedelic Report, Jesse Gould, Veteran Army Ranger and Founder of the Heroic Hearts Project, joins Dr. Dave Rabin to explore the implications of the recent FDA advisory committee vote on MDMA-assisted therapy for Veterans with PTSD. They highlight concerns over the influence of non-objective groups on the committee's decision and discuss the potential impact on millions of individuals seeking effective treatment for mental health challenges.
    Join the conversation as they explore the implications of disrupting the progress of a groundbreaking treatment and the importance of advocating for evidence-based therapies. Learn how you can get involved and make your voice heard to support the advancement of MDMA-assisted therapy for those who need it most.
    To take action and stay informed, visit Heroic Hearts and sign up for updates on upcoming initiatives. Let's come together to ensure access to life-changing treatments for Veterans and individuals suffering from PTSD.
    Don't miss this insightful discussion on the intersection of medicine, advocacy, and the future of psychedelic therapies. Subscribe to The Psychedelic Report for more thought-provoking episodes on the latest developments in psychedelic medicine and healing.

    FDA petition for MDMA-assisted therapy https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/

    Food and Drug Administration
    5630 Fishers Lane
    Rm. 1061
    Rockville, MD 20852
    Docket No. FDA-2024-N-193


    • Web: https://heroicheartsproject.org/our-story/
    • Twitter: https://twitter.com/DrDavidRabin
    • Instagram: https://www.instagram.com/drdavidrabin
    • Web: https://www.drdave.io/
    • Web: www.ApolloNeuro.com
    Más Menos
    51 m
  • The Status of MDMA Therapy and the Veteran Impact

    The Status of MDMA Therapy and the Veteran Impact
    Jul 10 2024
    In this compelling episode of The Psychedelic Report, Dr. Dave Rabin delves into the evolving landscape of psychedelic-assisted therapies with special guest Jon Lubecki, a veteran and prominent advocate for such treatments in Ukraine. The discussion centers on the recent FDA advisory committee setback, which resulted in a 10 to 1 vote against MDMA-assisted therapy due to lingering concerns about its safety and efficacy, particularly in post-treatment activities like driving. Jon provides a nuanced analysis of the hearing, pointing out significant conflicts of interest among some opponents who failed to disclose their affiliations with competing therapies like psilocybin and ketamine. He also examines the critical role of influential organizations such as ICER and Symposia, whose biased reports have swayed public and regulatory opinions against MDMA trials. With a fervent focus on the broader implications for mental health, especially for veterans suffering from PTSD, Jon underscores the inadequacy of current treatments and the transformative potential of MDMA-assisted therapy. He shares his personal journey from struggling with PTSD to becoming a leading advocate, passionately calling for the democratization of access to these promising therapies, transcending political and social boundaries.
    • Instagram: https://www.instagram.com/jonathanlubecky/
    • Web: www.mdmaptsd.org
    • Twitter: https://twitter.com/DrDavidRabin
    • Instagram: https://www.instagram.com/drdavidrabin
    • Web: https://www.drdave.io/
    • Web: www.ApolloNeuro.com

    Congressman Dan Crenshaw speaks out on the MDMA-assisted therapy controversy and the anti-Veteran agenda :
    https://www.instagram.com/reel/C8zsu2Wu7M0/?utm_source=ig_web_copy_link&igsh=MzRlODBiNWFlZA==

    FDA petition for MDMA-assisted therapy https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/

    Food and Drug Administration
    5630 Fishers Lane
    Rm. 1061
    Rockville, MD 20852
    Docket No. FDA-2024-N-193
    Más Menos
    42 m
  • The FDA, MDMA Therapy, and Tucker Max

    The FDA, MDMA Therapy, and Tucker Max
    Jun 24 2024
    In the latest episode of The Psychedelic Report, Dr. Dave Rabin shares the latest news on the MDMA-Assisted Therapy trials evaluation by the FDA Advisory Committee from June 4, who voted a surprising 10-1 that the risks of this breakthrough treatment outweigh the benefits. This was particularly astonishing to clinicians and researchers as described by Rachel Nuwer in her latest article in the BBC published on June 20. We’ll take a deep dive into this article and the discussion of safety and risks of MDMA-Assisted Therapy, followed by an enlightening conversation with award-winning author Tucker Max about his personal journey achieving a greater sense of safety with psychedelic-assisted therapy.


    Tucker discusses the importance of safety and integration practices in maximizing the benefits of psychedelic experiences. He emphasizes the role of journaling, psychotherapy, and lifestyle changes in supporting the integration process and facilitating personal growth. Tucker's journey highlights the profound impact of psychedelics on mental health, self-discovery, and relationships.
    Don't miss this insightful episode, where real-life experiences and expert perspectives converge to explore the healing potential of psychedelic medicines. Tune in now to embark on a journey of self-discovery and transformation with Tucker Max.


    Web: https://www.tuckermax.com/
    Twitter: https://twitter.com/DrDavidRabin
    Instagram: https://www.instagram.com/drdavidrabin
    Web: https://www.drdave.io/
    Web: www.ApolloNeuro.com


    Tucker’s Books: https://www.tuckermax.com/books/#:~:text=Tucker%20Max's%20first%20three%20books,success%20has%20meant%20his%20success.


    Article: FDA advisors voted against MDMA therapy – researchers are still fighting for it
    https://www.bbc.com/future/article/20240620-fda-advisors-voted-against-mdma-therapy-researchers-are-still-fighting-for-it


    Your Brain Explained Episode 1 - The MDMA Breakthrough: https://open.spotify.com/episode/4k4KWRzmn8o8N2Aer4MYAG?si=0377e20f02ed481d


    Rachel Nuwer’s NYT article breaking the study findings: https://www.nytimes.com/2023/09/14/health/mdma-ptsd-psychedelics.html


    Nature Medicine MDMA trial science article 1: https://www.nature.com/articles/s41591-021-01336-3


    Nature Medicine MDMA trial science article 2: https://www.nature.com/articles/s41591-023-02565-4


    Special episode of The Tim Ferriss Show with Dr. Dave Rabin on MDMA Therapy: https://open.spotify.com/show/5qSUyCrk9KR69lEiXbjwXM

    Food and Drug Administration
    5630 Fishers Lane
    Rm. 1061
    Rockville, MD 20852
    Docket No. FDA-2024-N-193
    Más Menos
    47 m
  • Understanding the Impact of the FDA Vote on MDMA Therapy with Rachel Nuwer

    Understanding the Impact of the FDA Vote on MDMA Therapy with Rachel Nuwer
    Jun 10 2024
    In this compelling episode of The Psychedelic Report, Dr. Dave Rabin is joined by esteemed journalist Rachel Nuwer, renowned for breaking the pivotal story on the Phase 3 MDMA-assisted therapy trials for PTSD in The New York Times. Together, they delve into the recent contentious votes from the FDA Pharmacologic Advisory Committee, which advised against approving MDMA-assisted therapy despite robust evidence from clinical trials.


    Rachel provides an insider's perspective on the committee's decision, expressing disappointment over the unreasonably high standards applied to MDMA-assisted therapy compared to other psychiatric medications. She and Dr. Rabin discuss the committee's focus on issues like demographic representation and the integration of therapy with MDMA treatment, arguing that these criticisms overlook the proven benefits of MDMA in enhancing psychotherapy outcomes.
    The episode highlights the need for better education on psychedelic therapy within the medical community and critiques the media's role in spreading public misconceptions. Rachel and Dr. Rabin emphasize the potential of MDMA-assisted therapy to revolutionize PTSD treatment, especially for Veterans and other underserved populations. Despite the setback, they remain hopeful that the scientific evidence and patients’ needs will ultimately prevail.

    Overall, the conversation underscores the importance of accurate reporting and increased awareness to advance psychedelic therapies and build public trust in these innovative treatments.

    Your Brain Explained - Can We Cute Mental Illness? The MDMA Story

    Apple: https://podcasts.apple.com/us/podcast/your-brain-explained/id1693658383?i=1000617879818

    Spotify:
    https://open.spotify.com/episode/4k4KWRzmn8o8N2Aer4MYAG?si=fd8c315823854dad

    Rachel Nuwer’s Breaking News on MDMA Phase 3 Trials Results in the NYT:
    https://www.nytimes.com/2023/09/14/health/mdma-ptsd-psychedelics.html

    Rachel Nuwer’s book I Feel Love: MDMA and the Quest for Connection in a Fractured World https://www.goodreads.com/book/show/62039306-i-feel-love

    Twitter: https://twitter.com/DrDavidRabin
    Instagram: https://www.instagram.com/drdavidrabin
    Web: https://www.drdave.io/
    Web: www.ApolloNeuro.com
    Más Menos
    36 m
  • Optimizing Psychedelic Medicine Experiences with Shawn Wells

    Optimizing Psychedelic Medicine Experiences with Shawn Wells
    May 21 2024
    In this episode of The Psychedelic Report, Dr. Dave Rabin explores the nexus of nutrition, supplementation, and optimizing psychedelic medicine experiences with Shawn Wells, an expert in diet, nutrition, and biochemistry. Shawn discusses the transformative impact of psychedelics on his life and emphasizes the importance of practices like fasting and dietary restriction to establish an optimal physiological baseline for meaningful journeys. They discuss how fasting can induce a ketogenic state, potentially enhancing neuroplasticity during psychedelic experiences. This conversation emphasizes the significance of preparation, both physically and mentally, for psychedelic experiences, highlighting the importance of adaptability, stress tolerance, and learning.
    • Web: https://shawnwells.com/
    • Instagram: https://www.instagram.com/shawnwells
    • Twitter: https://twitter.com/DrDavidRabin
    • Instagram: https://www.instagram.com/drdavidrabin
    • Web: https://www.drdave.io/
    • Web: www.ApolloNeuro.com
    Más Menos
    41 m
  • Exploring the Nexus of Sexuality, Health, and Longevity with Dr. Amy Killen

    Exploring the Nexus of Sexuality, Health, and Longevity with Dr. Amy Killen
    May 7 2024
    In this episode of The Psychedelic Report, Dr. Dave Rabin and Dr. Amy Killen delve into the profound correlation between sexuality, intimacy, and longevity. Dr. Killen, a physician, presents compelling research demonstrating that regular sexual activity is associated with reduced mortality rates, particularly in men, attributing this effect to the physiological impact of sexual experiences, including the release of neurotransmitters like dopamine, endorphins, serotonin, and oxytocin. They advocate for a comprehensive approach to sexual education, emphasizing self-exploration, effective communication, and the destigmatization of pleasure. This episode addresses societal taboos around sexuality and underscores the importance of prioritizing sexual health in healthcare practices. Overall, they challenge listeners to adopt a more open-minded and holistic perspective on sexuality, recognizing its profound impact on overall well-being and quality of life.
    • Web: https://dramykillen.com/
    • Instagram:https://www.instagram.com/dr.amybkillen/
    • Facebook: https://www.facebook.com/DrAmyBKillen/
    • Twitter: https://twitter.com/DrDavidRabin
    • Instagram: https://www.instagram.com/drdavidrabin
    • Web: https://www.drdave.io/
    • Web: www.ApolloNeuro.com
    Más Menos
    48 m